8 ASX All Ords shares upgraded to 'strong buy' ratings in November
S&P/ASX All Ords (ASX: XAO) shares soared 3.29% in November amid an early start to the traditional 'Santa Rally'.
AMP Ltd (ASX: AMP) Head of Investment Strategy and Economics, Dr Shane Oliver, said markets were now in a "seasonally strong period of the year".
He commented:
Our overall assessment remains that the trend is still up, including for Australian shares, but expect a more volatile and constrained ride.
Dr Oliver said the market was buoyed last month by Republican Donald Trump's decisive presidential election win in the United States.
Many of Trump's policies are seen as business-friendly, including his promise to lower US corporate taxes from 21% to 15% and to deregulate parts of the US tech sector.
He also plans to introduce tariffs on all nations, which partly contributed to a divergent performance across global markets last month.
Dr Oliver noted that the S&P 500 Index (SP: .INX) rose by 5.73% and ASX All Ords shares rose by 3.29%.
But Eurozone shares fell 0.1% and Japanese shares fell 2.2%, partly due to concerns over how the new tariffs may affect exports.
Meantime, various brokers made adjustments to their ASX stock ratings.
Here are eight ASX All Ords shares that market analysts on the CommSec trading platform upgraded to a consensus strong buy rating last month.
8 ASX All Ords shares lifted to 'strong buy' status
Syrah Resources Ltd (ASX: SYR)
The Syrah Resources share price closed at 22 cents on Tuesday, down 2.22%.
It's interesting that market analysts on CommSec raised the ASX All All Ords graphite stock to a strong buy rating while in the same week it was also one of the most shorted stocks on the market.
My colleague Seb recently discussed whether Syrah Resources shares are cheap following a 67% fall in 2024.
GQG Partners Inc (ASX: GQG)
The GQG Partners share price closed at $2.09 yesterday, up 3.47%.
Goldman Sachs has a buy rating on the stock with a 12-month share price target of $3. This implies a potential 44% upside for investors in 2025.
In a new note, analysts Julian Braganza and Brian Kim discussed the impact of the Adani saga:
GQG shares fell 19% following news that US prosecutors have charged senior Adani executives, including the chairman, in connection with an alleged bribery scheme.
GQG, which holds stakes in Adani entities through its funds, said they are monitoring the situation and assessing if any actions will be taken on their portfolios.
GQG noted that in aggregate in excess of 90% of client assets are invested in issuers unrelated to Adani Group, implying at most ~10% of FUM is exposed to Adani.
The ASX All Ords financial share is up 24% in the year to date.
PYC Therapeutics Ltd (ASX: PYC)
The PYC Therapeutics share price closed at $1.69 on Tuesday, up 0.6%.
PYC released a new investor presentation on its Polycystic Kidney Disease Program last week.
Canaccord Genuity has a buy rating on PYC shares with a 12-month share price target of $2.40. This implies a potential 42% upside for investors in 2025.
The ASX All Ords healthcare share is up 1,590% in the year to date (yep, you read that correctly!)
Gold Road Resources Ltd (ASX: GOR)
The Gold Road share price closed at $2 on Tuesday, down 1.96%.
Goldman Sachs has a buy rating on the stock and raised its 12-month share price target to $2.35.
In a new note, the broker said there was a potential positive for Gold Road if De Grey Mining Limited (ASX: DEG) shareholders approve the proposed takeover by Northern Star Resources Ltd (ASX: NST).
Gold Road owns about 17% of De Grey Mining shares and holds neighbouring leases to De Grey's Hemi gold project.
Goldman said the deal could potentially add about $800 million to Gold Road's already net cash balance sheet.
The broker added:
Furthermore, we see potential support for GOR to re-rate on its own fundamentals, with the stock currently trading at a significant discount to peers…
The ASX All Ords gold share is up 2% in the year to date.
Smartpay Holdings Ltd (ASX: SMP)
The Smartpay share price closed at 62 cents on Tuesday, up 0.81%.
The company released its FY25 half-year report last month.
The ASX All Ords financial share is down 56% in the year to date.
Dexus Industria REIT (ASX: DXS)
The Dexus Industria real estate investment trust (REIT) closed at $7.21 on Tuesday, up 0.42%.
UBS has a buy rating on the property stock with a 12-month share price target of $8.86.
This implies a potential upside of 23% for investors.
The ASX All Ords REIT is down 5% in the year to date.
Australian Agricultural Company Ltd (ASX: AAC)
The Australian Agricultural Company share price closed at $1.38 yesterday, down 0.72%.
Australian Agricultural Company released its FY25 half-year results on 15 November.
This ASX All Ords agriculture share is steady in the year to date.
Macquarie Technology Group Ltd (ASX: MAQ)
The Macquarie Technology share price closed at $87.94 on Tuesday, up 0.18%.
The company held its annual general meeting last week.
This ASX All Ords technology share is up 30% in the year to date.
The post 8 ASX All Ords shares upgraded to 'strong buy' ratings in November appeared first on The Motley Fool Australia.
Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2024